Conclusion:
Clinicians should keep in mind that Behcet’s disease is not uncommonly
associated with sensorineural hearing loss, and that anti-TNF and
steroid-sparing agents could help control the disease if other
modalities fail. Further studies are needed to prove the efficacy of
anti-TNF in this setting.